Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities.

Purpose: This retrospective study aims at investigating the effects of moderately hypofractionated radiation therapy (HRT) on acute and late toxicities as well as on early biochemical control and therapeutic efficiency compared to conventional radiation therapy (CRT) in prostate cancer.Patients and...

Descripción completa

Detalles Bibliográficos
Publicado en:Strahlentherapie und Onkologie Vol. 196; no. 7; pp. 598 - 608
Autores principales: Vassis, Stratos, Nöldeke, Beatrice, Christiansen, Hans, von Klot, Christoph A., Merten, Roland
Formato: Journal Article
Publicado: Springer Nature Jul2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=143855714&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 143855714
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01797158
        NZE
      jtl: Strahlentherapie und Onkologie
      issn: 01797158
      maglogo: N
    pubinfo:
      dt: Jul2020
      vid: 196
      iid: 7
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        143855714
        143855714
        144161666
        NLM32040691
        10.1007/s00066-020-01589-w
        NLM32040691
        143855714
      ppf: 598
      ppct: 10
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities.
      aug:
        au:
          Vassis, Stratos
          Nöldeke, Beatrice
          Christiansen, Hans
          von Klot, Christoph A.
          Merten, Roland
        affil: Department of Radiation Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hanover, Germany
      sug:
        subj:
          Adenocarcinoma Radiotherapy
          Prostatic Neoplasms Radiotherapy
          Radiotherapy, Conformal Methods
          Radiation Injuries Etiology
          Aged, 80 and Over
          Adenocarcinoma Blood
          Cystitis Pathology
          Gastrointestinal Diseases Prevention and Control
          Middle Age
          Male
          Adenocarcinoma Pathology
          Time Factors
          Prospective Studies
          Body Regions Radiation Effects
          Cystitis Etiology
          Urination Disorders Etiology
          Genitalia, Male Radiation Effects
          Genitalia, Male Pathology
          Bladder Radiation Effects
          Radiotherapy, Conformal Adverse Effects
          Radiation Injuries Prevention and Control
          Retrospective Design
          Rectum Radiation Effects
          Aged
          Rectal Diseases Etiology
          Prostatic Neoplasms Pathology
          Rectal Diseases Prevention and Control
          Prostate-Specific Antigen Blood
          Probability
          Prostatic Neoplasms Blood
          Therapeutics Methods
          Body Weights and Measures
          Gastrointestinal Diseases Etiology
          Urination Disorders Pathology
          Arthritis Impact Measurement Scales
          Aged, 80 & over
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
      ab: Purpose: This retrospective study aims at investigating the effects of moderately hypofractionated radiation therapy (HRT) on acute and late toxicities as well as on early biochemical control and therapeutic efficiency compared to conventional radiation therapy (CRT) in prostate cancer.Patients and Methods: We analyzed 55 HRT patients irradiated with the total dose of 60 Gy in 20 fractions delivered over 4 weeks. These patients were compared to a control group of 55 patients who received CRT with a total of <78 Gy in 37-39 fractions delivered over circa 8 weeks. External beam radiation therapy (EBRT) was conducted using daily image-guided (cone beam CT) volumetric modulated arc therapy (VMAT) and a simultaneously integrated boost (SIB) for both groups to protect the rectum. Acute toxicities were evaluated according to Common Terminology Criteria for Adverse Events (CTCAE) v5, whereas chronic toxicities were assessed in accordance with LENT-SOMA. Patient traits were compared by implementing t‑tests and Wilcoxon-Whitney tests for continuous variables, whereas discrete characteristics were evaluated by applying two-tailed Fisher's exact tests. In addition, we calculated average treatment effects (ATE). Thereby, propensity score matching (PSM) based on nearest-neighbor matching considering age, comorbidities, and risk stratification as covariates was applied. The statistical analysis was conducted using Stata 14.2 (StataCorp LLC, TX, USA).Results: As confirmed by the descriptive tests, the ATE revealed that the intensity and occurrence of urinary frequency (p = 0.034) and proctitis (p = 0.027) significantly decreased for the HRT group, whereas all other acute toxicities did not differ significantly between the HRT and CRT groups. For late toxicities, neither statistical tests nor ATE estimation showed significant differences. Also, no significant difference was found regarding the decrease in prostate specific antigen (PSA) after a median follow-up of 13 months (range 2-28 months), which indicates biochemical freedom from progression.Conclusion: HRT offers several medical and economic advantages and should therefore be considered as a useful alternative to CRT.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N